Aimee Horsfall, mentee in the 2019 MedTech-Pharma program in SA (The University of Adelaide)

Aimee graduated from a Bachelor of Science (Molecular & Drug Design) in 2015, with a double major in Chemistry from the University of Adelaide. She then went on to complete a Master of Philosophy in Chemical Science continuing at the University of Adelaide. Her research project focused on defining peptide secondary structure with a bifunctional fluorescent constraint, under the supervision of Prof. Andrew Abell.

Aimee is now in her third year of a PhD supervised by Prof. Andrew Abell & Dr. John Bruning. Her project concentrates on the design and synthesis of peptides which target protein-protein interactions. In particular, she has worked heavily on developing peptide-based therapeutics which may be of use as broad spectrum cancer therapeutics. Much of this work has been carried out in collaboration with CSIRO (Clayton). As a member of the ARC Centre of Excellence for Nanoscale Biophotonics (CNBP) and Institute for Photonics and Advanced Sensing (IPAS), Aimee has also worked on a number of projects in which she has functionalised peptides with fluorescent sensor molecules, designed and synthesised peptide biosensors for live-cell protein detection and developed peptide materials for adhesive applications. The interdisciplinary approach and translation focus employed by both the CNBP and IPAS, has piqued her interest in the large variety of applications her science or career may pursue, including those in Industry.

You can find Aimee on:



The University of Adelaide Researcher Profile